Geneferm Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 07, 2019 at 06:29 pm
Share
GeneFerm Biotechnology Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 80.843 million compared to TWD 82.707 million a year ago. Operating loss was TWD 352,000 compared to operating Income of TWD 342,000 a year ago. Net loss was TWD 2.362 million compared to net income of TWD 1.406 million a year ago. Basic loss per share was TWD 0.08 compared to basic earnings per share of TWD 0.05 a year ago. For the nine months, sales was TWD 232.985 million compared to TWD 250.926 million a year ago. Operating loss was TWD 13.636 million compared to operating Income of TWD 2.195 million a year ago. Net loss was TWD 15.901 million compared to net income of TWD 4.637 million a year ago. Basic loss per share was TWD 0.57 compared to basic earnings per share of TWD 0.17 a year ago.
GeneFerm Biotechnology Co., Ltd. is a Taiwan-based company mainly engaged in the manufacture and sales of health food. Its health food products include fermented products, medicinal mushrooms, lactic acid bacteria products, fruit and vegetable fermented concentrate products, among others. The Company also provides related manufacturing services, as well as health food design, research and development services.